Skip to main navigation Skip to search Skip to main content

First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalJournal of Neurosurgery: Pediatrics
Volume23
StatePublished - Apr 5 2019

Cite this